News articles about Surgery Partners (NASDAQ:SGRY) have been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Surgery Partners earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 47.0298198599651 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
These are some of the news stories that may have effected Accern’s rankings:
- Short Interest Moves 18% Higher For SGRY (thestreet.com)
- Edited Transcript of SGRY earnings conference call or presentation 9-Nov-17 1:30pm GMT (finance.yahoo.com)
- Analysts Expect Surgery Partners, Inc. (SGRY) Will Announce Quarterly Sales of $314.12 Million (americanbankingnews.com)
- Surgery Partners’ (SGRY) Management on Q3 2017 Results – Earnings Call Transcript (msn.com)
- Surgery Partners, Inc. Announces Third Quarter 2017 Results (nasdaq.com)
A number of analysts have weighed in on SGRY shares. BidaskClub cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Zacks Investment Research raised shares of Surgery Partners from a “hold” rating to a “buy” rating and set a $22.00 target price on the stock in a report on Wednesday, August 2nd. Stifel Nicolaus cut shares of Surgery Partners from a “hold” rating to a “sell” rating and dropped their target price for the stock from $21.00 to $17.00 in a report on Wednesday, August 9th. Raymond James Financial, Inc. reissued a “market perform” rating on shares of Surgery Partners in a report on Wednesday, August 9th. Finally, Citigroup Inc. reissued a “buy” rating and set a $17.00 target price (down from $28.00) on shares of Surgery Partners in a report on Friday, August 11th. Four analysts have rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $18.86.
Surgery Partners (NASDAQ:SGRY) opened at $9.45 on Friday. Surgery Partners has a 12-month low of $7.10 and a 12-month high of $24.05. The company has a debt-to-equity ratio of 5.69, a current ratio of 1.89 and a quick ratio of 1.73. The stock has a market cap of $460.87, a PE ratio of 63.00 and a beta of 1.92.
In other Surgery Partners news, major shareholder H.I.G. Surgery Centers, Llc sold 26,455,651 shares of the company’s stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $19.00, for a total value of $502,657,369.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 7.60% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION WARNING: This news story was posted by Markets Daily and is the sole property of of Markets Daily. If you are viewing this news story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The original version of this news story can be viewed at https://www.themarketsdaily.com/2017/11/12/surgery-partners-sgry-earns-coverage-optimism-score-of-0-21.html.
Surgery Partners Company Profile
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.